Intestinal growth-promoting properties of glucagon-like peptide-2 in mice

  • C. H. Tsai
    Department of Medicine, Banting and Best Diabetes Centre, TorontoHospital, University of Toronto, Ontario, Canada.
  • M. Hill
    Department of Medicine, Banting and Best Diabetes Centre, TorontoHospital, University of Toronto, Ontario, Canada.
  • S. L. Asa
    Department of Medicine, Banting and Best Diabetes Centre, TorontoHospital, University of Toronto, Ontario, Canada.
  • P. L. Brubaker
    Department of Medicine, Banting and Best Diabetes Centre, TorontoHospital, University of Toronto, Ontario, Canada.
  • D. J. Drucker
    Department of Medicine, Banting and Best Diabetes Centre, TorontoHospital, University of Toronto, Ontario, Canada.

書誌事項

公開日
1997-07-01
DOI
  • 10.1152/ajpendo.1997.273.1.e77
公開者
American Physiological Society

この論文をさがす

説明

<jats:p> Glucagon-like peptide-2 (GLP-2) has been shown to promote intestinal epithelial proliferation. We studied crypt cell proliferation, enterocyte cell death, and feeding behavior in GLP-2-treated mice. GLP-2 had no effect on food consumption [7.7 +/- 0.3 vs. 8.0 +/- 0.4 g/day, saline (control) vs. GLP-2-treated mice, P = not significant]; however, GLP-2 increased the crypt cell proliferation rate (46.0 +/- 1 vs. 57 +/- 5%, control vs. GLP-2, P < 0.01) and decreased the enterocyte apoptotic rate (5.9 +/- 0.7 vs. 2.8 +/- 0.2% apoptotic cells, control vs. GLP-2, P < 0.05) in small bowel (SB) epithelium. GLP-2 induced a significant increase in SB weight (1.3- to 1.75-fold increase over control, P < 0.05 to P < 0.001) in mice 1-24 mo of age. Increased SB weight was maintained after daily administration of GLP-2 to mice for 12 wk, and cessation of GLP-2 administration in older mice led to regression of (increased) SB weight and mucosal height. These observations suggest that GLP-2 regulates both cell proliferation and apoptosis and promotes intestinal growth after both short- and long-term administration in vivo. </jats:p>

収録刊行物

被引用文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ